News and Comments

COULD AGENUS VACCINE FOR GLIOBLASTOMA BE ASSIGNED BREAKTHROUGH DESIGNATION?

  Tuesday, September 17, 2013

AGENUS (AGEN) has extraordinary news. A recent analysis from a Phase 2 trial in patients with newly diagnosed glioblastoma multiforme (GBM) treated with Prophage Series G-100 (HSPPC-96) in combination with the current standard of care (radiation and temozolomide) showed an almost 18 month median progression free survival (PFS), which represents a 160% increase versus current standard of care alone. The results confirm continuation of the positive trends from the Phase 2 HSPPC-96 newly diagnosed GBM trial first reported at the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in May 2013. More...

AGENUS OFFERS AN INVESTMENT OPPORTUNITY.

  Saturday, September 07, 2013

 More...


Recent Postings


Archive


Tags

Advaxis (ADXS) Alder Biopharmaceuticals (ALDR) CRISPR Therapeutics (CRSP) Endometrial Cancer SUNESIS PHARMACEUTICALS (SNSS) Biogen Idec (BIIB) SYNTA (SNTA) ACADIA (ACAD) OSI (OSIP) Auspex (ASPX) ZALTRAP™ ADVENTRIX (ANX) Galena (GALE) KERYX (KERX) Theravance (THRX) GlaxoSmithKline (GSK) TOKAI (TKAOI) BIOMARIN (BMRN) ARCA (ABIO) Adaptimmune (ADAP) Sanofi (SNY) Ziofpharm (ZIOP) SERES THERAPEUTICS (MCRB) Intrexon (XON) KITE (KITE) Incyte (INCY) CompuGen (CGEN) Rapamune Alnylam (ALNY) RenenxBio (RGNX) INNOVIVA (INVA) Vitae Pharmaceuticals (VTAE) Exelixis (EXEL) ARGOS (ARGS) AGOS (ARGS) Jazz Pharmaceuticals (JAZZ) Gilead (GILD) AERIE PHARMACEUTICALS Onyx (ONXX) Trastuzumab-DM1 Revlimid (lenolidamide) Prosensa (RNA) Micromet (MITI) NEKTAR (NKTR)) Prolor Biotech (PBTH) ABBVIE (ABBV) Sequenom (SQNM) Zerenex IDERA (IDRA) Merck (MRK) MODERNA Roche (RHHBY) Aimmune Therapeutics (AIMT) AstraZeneca (AZN) Array Pharmaceuticals (ARRY) Abbott Laboratories (ABT) CEMPRA (CEMP) Sanofi-Aventis (SAN) Human Genome Sciences (HGSI) Spike Therapeutics (ONCE) Ionis (IONS) NANTKWEST (NK) Illumina (ILMN) Seattle Genetics (SGEN) REGULUS (RGLS) Idenix (IDIX) C4 Therapeutics Bellicum (BLCM) VANDA (VNDA) Cytokinetics (CYTK) Agenus (AGEN) Multiple Myeloma Sarepta (SRPT) Vertex (VRTX) Anadys (ANDS) Xoma (XOMA) Mirati Therapeutics (MRTX) Herceptin Dendreon (DNDN) Ariad (ARIA) Sangamo (SGMO) ISIS (ISIS) Intercept (ICPT) Agenus (AGEN Telaprevir Intermune (ITMN) ImmunoGen (IMGN) Elan (ELN) Editas (EDIT) JUNO (JUNO) Regeneron (REGN) Pluristem (PSTI) Ridaforolimus Dynavax (DVAX) Genentech Amgen (AMGN) PTC Therapeutics (PTCT) Benlysta (belimumab) Anacor (ANAC) Valeant Pharmaceuticals International (VRX) Sanofi (SNA) Global Cell Therapeutics (GBT) Biocryst (BCRX) HALOZYME (HALO) galapagos (GLPG) GUARDIAN HEALTH Ocular Therapeutix (OCUL) NOVOCURE (NVCR) Inovio (INO) Theravance Bio Pharma (TBPH) Roche (ROCHE) PORTOLA (PTLA) Velcade (bortezomib) Bristol-Myers Squibb (BMY) Tysabri Human Longevity (HLI)